Optimind Pharma Corp. (OMND.CN)
Optimind Pharma Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.01, down 50.00% on the session, giving a market capitalisation of $515,742. Its beta of 0.14 implies it has historically moved less than the broad market.
Optimind Pharma Corp. is a Canadian pharmaceutical enterprise headquartered in Toronto. The company specializes in offering psychedelic-based therapies, including ketamine-assisted treatment and other advanced psychedelic-enhanced psychotherapy modalities, targeting mental health conditions such as post-traumatic stress syndrome, anxiety, depression, and various other psychological disabilities. Additionally, Optimind Pharma operates a dedicated clinic that provides patients with medical cannabis and a range of alternative medical treatments, notably featuring ketamine-enhanced psychotherapy as part of its offerings.
Optimind Pharma Corp. is most often compared with the following Healthcare names: